Shen Tian , Xingyong Wu , Lin Liu , Anyang Li , Xuemiao Li , Hua Pei , Yanshuang Wang , David A.B. Dance , Hai Chen , Qianfeng Xia
{"title":"中国假丝酵母伯克霍尔德菌对头孢唑肟耐药性的 PenA 基因点突变 P174L","authors":"Shen Tian , Xingyong Wu , Lin Liu , Anyang Li , Xuemiao Li , Hua Pei , Yanshuang Wang , David A.B. Dance , Hai Chen , Qianfeng Xia","doi":"10.1016/j.drup.2024.101121","DOIUrl":null,"url":null,"abstract":"<div><p>In a clinical isolate of <em>Burkholderia pseudomallei</em> from Hainan, the association between the emergence of ceftazidime resistance and a novel PenA P174L allele was identified for the first time, providing an understanding of one mechanism by which ceftazidime resistance arises in <em>B. pseudomallei</em>.</p></div>","PeriodicalId":51022,"journal":{"name":"Drug Resistance Updates","volume":"76 ","pages":"Article 101121"},"PeriodicalIF":15.8000,"publicationDate":"2024-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Point mutation P174L of the penA gene endowing ceftazidime resistance to Burkholderia pseudomallei in China\",\"authors\":\"Shen Tian , Xingyong Wu , Lin Liu , Anyang Li , Xuemiao Li , Hua Pei , Yanshuang Wang , David A.B. Dance , Hai Chen , Qianfeng Xia\",\"doi\":\"10.1016/j.drup.2024.101121\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>In a clinical isolate of <em>Burkholderia pseudomallei</em> from Hainan, the association between the emergence of ceftazidime resistance and a novel PenA P174L allele was identified for the first time, providing an understanding of one mechanism by which ceftazidime resistance arises in <em>B. pseudomallei</em>.</p></div>\",\"PeriodicalId\":51022,\"journal\":{\"name\":\"Drug Resistance Updates\",\"volume\":\"76 \",\"pages\":\"Article 101121\"},\"PeriodicalIF\":15.8000,\"publicationDate\":\"2024-07-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug Resistance Updates\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1368764624000797\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Resistance Updates","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1368764624000797","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Point mutation P174L of the penA gene endowing ceftazidime resistance to Burkholderia pseudomallei in China
In a clinical isolate of Burkholderia pseudomallei from Hainan, the association between the emergence of ceftazidime resistance and a novel PenA P174L allele was identified for the first time, providing an understanding of one mechanism by which ceftazidime resistance arises in B. pseudomallei.
期刊介绍:
Drug Resistance Updates serves as a platform for publishing original research, commentary, and expert reviews on significant advancements in drug resistance related to infectious diseases and cancer. It encompasses diverse disciplines such as molecular biology, biochemistry, cell biology, pharmacology, microbiology, preclinical therapeutics, oncology, and clinical medicine. The journal addresses both basic research and clinical aspects of drug resistance, providing insights into novel drugs and strategies to overcome resistance. Original research articles are welcomed, and review articles are authored by leaders in the field by invitation.
Articles are written by leaders in the field, in response to an invitation from the Editors, and are peer-reviewed prior to publication. Articles are clear, readable, and up-to-date, suitable for a multidisciplinary readership and include schematic diagrams and other illustrations conveying the major points of the article. The goal is to highlight recent areas of growth and put them in perspective.
*Expert reviews in clinical and basic drug resistance research in oncology and infectious disease
*Describes emerging technologies and therapies, particularly those that overcome drug resistance
*Emphasises common themes in microbial and cancer research